Cullen corylifolium

Cullen corylifolium · Accepted scientific name

Scientific literature: Very Sparse (15 studies) · ★☆☆☆☆

Cullen corylifolium is a significant medicinal plant known for its diverse therapeutic activities, including antioxidant, antibacterial, anticancer, and antitumor properties. The seeds and fruits of this species serve as primary sources for potent bioactive compounds such as Bakuchiol, Psoralen, ISOPSORALEN, and Psoralidin. Researchers frequently utilize various preparations, ranging from aqueous and 70% EtOH extracts to complex polysaccharides, to harness these chemical constituents. These extracts are studied for their potential to manage various medical conditions, including vitiligo, psoriasis, enuresis, and osteoporosis. Consequently, this plant remains a focal point of pharmacological interest due to its rich chemical profile and multifaceted biological benefits.

Quick facts
Synonyms
Dorychnium Corylifolium · Lotodes Corylifolium · 5 more
Common names
Not available
Family
Fabaceae
Distribution
Australasia
Plant Parts
Seed · Fruit

Classification

Common Names

Cullen corylifolium is a versatile plant known by a diverse array of regional and traditional names. In various cultural contexts, it is frequently referred to as Babachi or Bauchi. It is also widely recognized by the moniker Blackdot, reflecting its unique physical characteristics. Many people familiar with traditional herbalism identify it by its Chinese name, Bu Gu Zhi. Additionally, it is commonly called Indian Bread Root, showcasing the many identities this single species holds across the globe.

Sources: Catalogue of Life (COL)

Synonyms

Cullen corylifolium is a botanical species known to be associated with several different taxonomic names. Within scientific literature, it is recognized by the synonym Bipontinia corylifolia as well as Dorychnium corylifolium. The plant is also frequently identified under the name Lotodes corylifolia, including its specific variety Lotodes corylifolia var. parvifolium. Furthermore, researchers may encounter this species listed under the synonym Psoralea corylifolia. Understanding these various designations is essential for accurately tracking the plant's identity across different botanical records.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Cullen corylifolium is a remarkable botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. The plant is further categorized into the order Fabales, reflecting its unique evolutionary lineage. It holds a distinguished position within the family Fabaceae, a group known for its diverse members. Ultimately, this species is identified by its scientific placement within the genus Cullen.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Fabales
Family Fabaceae
Genus Cullen

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Cullen corylifolium exhibits a diverse distribution that spans several key regions across the African continent. It is notably found throughout Northeast Tropical Africa, with specific occurrences in Djibouti, Somalia, and the island of Socotra. The plant's range also extends into the Western Indian Ocean, where it thrives in unique island environments. Specifically, populations have been documented in both Mauritius and Réunion. This wide geographic spread highlights the plant's ability to adapt to various coastal and tropical habitats.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Cullen corylifolium is a self-supporting herb characterized by its compact and sturdy growth form. This plant typically reaches a modest maximum height of only 0.6 meters. Such a structured profile makes it a distinctive feature within its natural habitat.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Cullen corylifolium, also known as Psoralea corylifolia, is a medicinal plant recognized for its diverse and potent pharmacological profile. Research indicates that its bioactive compounds exhibit significant antioxidant activity, helping to combat oxidative stress within biological systems. Furthermore, the plant demonstrates strong antibacterial properties, with specific constituents showing efficacy against various microbial strains. Its therapeutic potential extends to oncology, as various extracts have shown promising anticancer and antitumor activities against several cancer cell lines. Additionally, the plant plays a role in metabolic health, demonstrating notable antidiabetic activity through the inhibition of key enzymes and regulators.

Compounds

Cullen corylifolium is a medically significant plant recognized for its diverse array of bioactive chemical constituents. Research indicates that the plant contains several important furanocoumarins, specifically psoralen and isopsoralen. In addition to these compounds, the plant serves as a source of the meroterpene bakuchiol, which is noted for its antioxidant properties. Further phytochemical analysis has also identified the presence of psoralidin and corylin within its various extracts. Together, these diverse compounds contribute to the wide range of therapeutic applications associated with the species.

Conditions

Cullen corylifolium provides significant therapeutic benefits by treating vitiligo and psoriasis through its bioactive components. The plant also demonstrates immense anticancer potential, as evidenced by the cytotoxicity of its various coumarins and isoflavones. Its pharmacological profile includes strong anti-inflammatory properties that assist in managing chronic conditions. Additionally, the plant exhibits effective antibacterial activities, particularly through substances like isobavachalcone. These diverse relationships highlight the plant's versatile role in addressing multiple medicinal needs.

Preparations

Cullen corylifolium is prepared as seeds to isolate chemical constituents such as new flavonoids and known compounds like psoralen. This plant is also prepared as 70% EtOH extracts to assess in vitro estrogenic activities. Researchers utilize Cullen corylifolium prepared as aqueous extracts to investigate the inhibition of keratinocyte replication. Furthermore, the plant is prepared as polysaccharides to study their ability to alleviate immunosuppression by modulating gut microbiota. Finally, Cullen corylifolium is prepared as alcohol extracts, which can be optimized through flattening processes to increase the content of active components like psoralen.

Parts used

Cullen corylifolium is a medicinal plant that possesses significant pharmacological potential through its various biological components. Research indicates that the plant has part seed, which serves as a rich source of bioactive flavonoids and chemical constituents. These isolated seed compounds have demonstrated the ability to inhibit diacylglycerol acyltransferase, offering potential benefits in combating obesity. Furthermore, the plant has part fruit, often referred to as Psoralea fructus, which is utilized for its therapeutic properties. Specifically, the dried and ripe fruit has shown promising anti-cancer activity by suppressing the proliferation of human colorectal cancer cells.